- Home
- XFOR vs ALTO Comparison
XFOR vs ALTO Comparison
Compare XFOR & ALTO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | XFOR | ALTO |
|---|---|---|
| Founded | 2014 | 2003 |
| Country | United States | United States |
| Employees | 143 | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Major Chemicals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 407.5M | 349.4M |
| IPO Year | N/A | 2005 |
Fundamental Metrics
Financial Performance| Metric | XFOR | ALTO |
|---|---|---|
| Price | $4.10 | $5.25 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $9.00 | N/A |
| AVG Volume (30 Days) | 399.2K | ★ 1.3M |
| Earning Date | 05-04-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 119.51 |
| EPS | N/A | ★ 0.16 |
| Revenue | N/A | ★ $917,927,000.00 |
| Revenue This Year | N/A | $6.66 |
| Revenue Next Year | N/A | $0.43 |
| P/E Ratio | ★ N/A | $33.13 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.35 | $0.80 |
| 52 Week High | $6.63 | $5.35 |
Technical Indicators
Market Signals| Indicator | XFOR | ALTO |
|---|---|---|
| Relative Strength Index (RSI) | 49.78 | 67.79 |
| Support Level | $3.41 | $0.98 |
| Resistance Level | $4.54 | N/A |
| Average True Range (ATR) | 0.24 | 0.28 |
| MACD | -0.01 | 0.00 |
| Stochastic Oscillator | 41.67 | 92.65 |
Price Performance
Historical ComparisonAbout XFOR X4 Pharmaceuticals Inc.
X4 Pharmaceuticals Inc is a biopharmaceutical company developing and commercializing novel therapeutics for the treatment of rare diseases of the immune system. The Company's lead clinical candidate is mavorixafor, a small molecule antagonist of the chemokine receptor CXCR4 that is being developed as an oral, once-daily therapy. It can increase the mobilization of mature, functional white blood cells from the bone marrow into the bloodstream. It also has two pre-clinical candidates X4P-003 and X4P-002 which are CXCR4 antagonists with different properties.
About ALTO Alto Ingredients Inc.
Alto Ingredients Inc is a producer and distributor of specialty alcohols, renewable fuels and essential ingredients in the United States. The company serves five markets: Health, Home and Beauty, Food and Beverage, Essential Ingredients, and Renewable Fuels. Its customers include food and beverage companies and consumer products manufacturers and distributors. The company operates under three segments: Marketing and distribution, Pekin Campus production, and Western production.